Raymond James & Associates’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,108
| Closed | -$22.7K | – | 3950 |
|
|
2024
Q2 | $22.7K | Sell |
1,108
-50
| -4% | -$1.02K | ﹤0.01% | 3831 |
|
|
2024
Q1 | $52.3K | Sell |
1,158
-26
| -2% | -$1.17K | ﹤0.01% | 3760 |
|
|
2023
Q4 | $55.9K | Buy |
1,184
+135
| +13% | +$6.37K | ﹤0.01% | 3655 |
|
|
2023
Q3 | $42.4K | Sell |
1,049
-117
| -10% | -$4.73K | ﹤0.01% | 3652 |
|
|
2023
Q2 | $124K | Buy |
1,166
+288
| +33% | +$30.7K | ﹤0.01% | 3539 |
|
|
2023
Q1 | $262K | Sell |
878
-118
| -12% | -$35.2K | ﹤0.01% | 3295 |
|
|
2022
Q4 | $342K | Buy |
996
+247
| +33% | +$84.9K | ﹤0.01% | 3122 |
|
|
2022
Q3 | $142K | Sell |
749
-21
| -3% | -$3.98K | ﹤0.01% | 3512 |
|
|
2022
Q2 | $163K | Buy |
770
+86
| +13% | +$18.2K | ﹤0.01% | 3546 |
|
|
2022
Q1 | $229K | Buy |
+684
| New | +$229K | ﹤0.01% | 3557 |
|
|
2021
Q4 | – | Sell |
-508
| Closed | -$247K | – | 3977 |
|
|
2021
Q3 | $247K | Buy |
508
+55
| +12% | +$26.7K | ﹤0.01% | 3526 |
|
|
2021
Q2 | $211K | Buy |
+453
| New | +$211K | ﹤0.01% | 3621 |
|
|
2020
Q4 | – | Sell |
-1,009
| Closed | -$700K | – | 3626 |
|
|
2020
Q3 | $700K | Buy |
+1,009
| New | +$700K | ﹤0.01% | 2396 |
|